The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Volume 16 - 2025 |
doi: 10.3389/fphar.2025.1484292
This article is part of the Research Topic Insights in Experimental Pharmacology and Drug Discovery: 2024 View all 4 articles
Ursodeoxycholic and chenodeoxycholic bile acids alleviate endotoxininduced acute lung injury in rats by modulating aquaporin expression and pathways associated with apoptosis and inflammation
Provisionally accepted- 1 Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 2 Department of Hygiene, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 3 Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 4 Centre for Biomedical Research; Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 5 Centre for Biomedical Research; Department of Histology and Embryology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 6 Centre for Biomedical Researche, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 7 Centre for Biomedical Research; Department of Medical Biochemistry and Chemistry, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 8 Centre for Biomedical Research; Department of Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 9 University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 10 Centre for Biomedical Research; Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
- 11 Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Vojvodina, Serbia
- 12 Department of Pathophysiology, I.M. Sechenov First Moscow State Medical University, Moscow, Moscow Oblast, Russia
- 13 Department of Histology and Embryology, Faculty of Medicine, University of Niš, Niš, Serbia
- 14 Center for Biomedical Research; Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
This study aimed to investigate the anti-inflammatory, antioxidant, and anti-apoptotic properties of ursodeoxycholic (UDCA) and chenodeoxycholic (CDCA) bile acids in a rat model of endotoxin (lipopolysaccharide, LPS)-induced acute lung injury (ALI). The study included six groups of Wistar rats exposed to different pretreatments. The control and endotoxin groups were pretreated with propylene glycol, a solvent for bile acids, while the other groups received UDCA or CDCA for 10 days. On the 10th day, an endotoxin injection was given to evaluate the impact of these pretreatments. Lung tissue sections were analyzed by immunohistochemistry, targeting the proinflammatory marker nuclear factor kappa B (NF-κB), the anti-apoptotic marker B-cell lymphoma 2 (BCL-2), pro-apoptotic markers BCL-2-associated X protein (BAX) and caspase 3, as well as the aquaporins 1 and 5 (AQP1 and AQP5). Oxidative stress was assessed in bronchoalveolar lavage fluid (BALF). This study demonstrates that UDCA and CDCA can mitigate endotoxin-induced lung injury in rats. These effects are achieved through modulation of AQP1 and AQP5 expression, reduction of oxidative stress, regulation of apoptotic pathways (BAX, caspase 3, BCL-2), and attenuation of proinflammatory activity of NF-κB. Although the results indicate a significant association between the expression of these proteins and histopathological changes, the potential influence of additional factors cannot be excluded. These findings suggest that UDCA and CDCA provide lung protection by acting through complex mechanisms involving inflammatory, oxidative, and apoptotic pathways.
Keywords: Chenodeoxycholic acid1, Ursodeoxycholic acid2, Endotoxin3, acute lung injury4, Oxidative stress5, inflammation6, Apoptosis7, Aquaporins8
Received: 21 Aug 2024; Accepted: 06 Feb 2025.
Copyright: © 2025 Milivojac, Grabež, Amidžić, Prtina, Krivokuća, Maličević, Barudžija, Matičić, Uletilović, Mandić-Kovačević, Cvjetković, Stojiljkovic, Gajić Bojić, Mikov, Gajanin, Bolevich, Petrović and Škrbić. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ranko Škrbić, Center for Biomedical Research; Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.